Krebs Biochemicals and Industries Limited — Others, 12-11-2024: Copy of Newspaper Publication

Krebs Biochemicals & Industries Limited has announced a board meeting to approve the financial results for the quarter and half-year ended 30th September 2024. The unaudited results show a total income from operations of Rs. 25.87 crore, a net loss after tax of Rs. 10.93 crore, and basic earnings per share of Rs. (5.07). This decline in profitability reflects ongoing operational challenges, which may influence investor sentiment, posing potential risks in the near term but also highlighting opportunities for future recovery if strategic adjustments are pursued.